-
Walsh, C.M., Glass, A.A., Chiu, V., and W.R. Clark. 1994. The role of the Fas lytic pathway in a perforin-less CTL hybridoma.Journal of Immunology, 153(6):2506-2514.
-
Walsh, C.M., Matloubian, M., Liu, C.-C., Ueda, R., Kurahara, C.G., Christensen, J.L., Huang, M.T.F., Young, J.D.-E, Ahmed, R., and W.R. Clark. Immune function in mice lacking the perforin gene.Proceedings of the National Academy of Sciences, USA91:10854-10858.
-
Chiu, V.K.,Walsh, C.M., Liu, C.-C., Reed, J.C., W.R. Clark. 1995.bcl-2blocks degranulation- but not fas-based cell-mediated cytotoxicity.Journal of Immunology154: 2023-2032.
-
Clark, W.R.,Walsh, C.M., Glass, A.A., M.T.F. Huang, Ahmed, R., and M. Matloubian. 1995. Cytotoxic responses in perforin-less mice.International Reviews of Immunology13: 1-14.
-
Liu, C.-C.,Walsh, C.M., and J.D.-E. Young. 1995. Perforin: Structure and Function.Immunology Today16: 194-201.
-
Clark, W.R.,Walsh, C.M., Glass, A.A., Hayashi, F., Matloubian, M., Ahmed, R. 1995. Molecular pathways of CTL-mediated cytotoxicity.Immunological Reviews146: 33-44.
-
Liu, C.-C.,Walsh, C.M., Eto, N., Clark, W.R., Young J.D-E. 1995. Morphological and functional characterization of perforin-deficient lymphokine activated killer cells.Journal of Immunology. 155: 602-608.
-
Glass, A.,Walsh, C.M., Lynch, D.H. and Clark, W.R. 1996. Regulation of the Fas lytic pathway in cloned CTL.Journal of Immunology156: 3638-44.
-
Walsh C.M., Hayashi F., Saffran D.C., Ju S-T, Berke G, Clark W.R. 1996. Cell-mediated cytotoxicity results from, but may not be critical for, primary allograft rejection.Journal of Immunology156: 1436-41.
-
Clark, W.R.,Walsh, C.M., Matloubian, M., Glass, A.A., Hayashi, F. 1996. Mechanisms of CTL-mediated cytotoxicity.Seminars in Virology7: 113-116.
-
Spencer MJ,Walsh C.M., Dorshkind KA, Rodriguez EM, Tidball JG. 1997. Myonuclear apoptosis in dytrophic mdx muscle occurs by perforin-mediated cytotoxicity.J. Clin. Invest.99: 2745-2751.
-
Walsh C.M., Wen B.G., Chinnayan A.M., O’Rourke K.O., Dixit V.M., Hedrick S.M. 1998. A role for FADD in T cell activation and development.Immunity8: 439-449.
-
Matloubian M., Suresh M., Glass A., Galvan M., Chow K., Whitmire J.K.,Walsh C.M., Clark W.R., Ahmed R. 1999. A role for perforin in downregulating T-cell responses during chronic viral infection.J Virol.73: 2527-36.
-
BeisnerD., Chu I.H., Arechiga A.F., Hedrick S.M.,Walsh C.M. 2003. The requirements for FADD signaling in mature T cell activation and survival.Journal of Immunology17: 247-56.
-
Walsh C.M., Luhrs K.A., Arechiga A.F. 2003. The “fuzzy logic” of the death-inducing signaling complex in lymphocytes.Journal of Clinical Immunology23:333-353.
-
Li C., Arechiga A.F., Melo J.V.,Walsh C.M., Ong S.T. 2003. Bcr-Abl Kinase Modulates the Translation Regulators Ribosomal Protein S6 and 4E-BP1 in Chronic Myelogenous Leukemia Cells via mTOR.Cancer Research63:5716-5722.
-
McCargill M., Wen B.,Walsh C.M., Hedrick S.M. 2004.A deficiency inDrak2results in a T cell hypersensitivity, and an unexpected resistance to autoimmunity.Immunity21:781-791.
-
Friedrich M.L., Wen B.G., Bain G., Kee B., Murre C., Hedrick S.M.,Walsh C.M.2005.DRAK2, a lymphoid-enriched DAP kinase, regulates the T cell receptor activation threshold during thymocyte selection.International Immunology,17: 1379-1390.
-
Arechiga A.F., Bell B.D., Solomon J.C., Chu I.H., Dubois C.L., Hall B.E., George T.C., Coder D.M.,Walsh C.M.2005.Cutting Edge- FADD is not required for antigen receptor mediated NF-kappaB activation.Journal of Immunology 175: 7800-7804.
-
Sandu S., Morisawa G., Wegorzewska I., Huang T., Arechiga A.F., Hill J.M., Kim T.,Walsh C.M., Werner M.H. 2006. FADD self-association is required for stable association with an activated death receptor.Cell Death and Differentiation 13: 2052-2061.
-
Choudhary S.K., Walker R.M., Powell D.M., Planelles V.,Walsh C., Camerini D. 2006. CXCR4 Tropic Human Immunodeficiency Virus Type 1 Induces an Apoptotic Cascade in Immature Infected Thymocytes that Resembles Thymocyte Negative Selection.Virology 352:268-84.
-
Werner M.H., Wu C.,Walsh, C.M.2006. Perspective - Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation.Cell Cycle 5(20): 2332-38.
-
Ramos S.J.*, Hardison J.L.*, Stiles L.N., Lane T.E.,Walsh C.M.2007. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.Autoimmunity 40: 54-65.
-
Doskaya M., Kalantari-Dehaghi M.,Walsh C.M., Hiszczynska-Sawicka E., Davies D.H., Felgner P.L., Larsen L.S.Z., Lathrop R.H., Hatfield G.W., Schulz J.R., Yuksel G., Jurnak F. 2007. GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine.Vaccine 25:1824-1837.
-
Friedrich M.L., Cui M., Hernandez J.B., Weist B.M., Andersen H.M., Zhang X., Huang L.,Walsh C.M.2007. Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes.Journal of Biological Chemistry 282: 4573-84.